MedKoo Cat#: 532083 | Name: L-750,667 TriHydrochloride
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

L-750,667 TriHydrochloride is a selective D4 dopamine receptor antagonist.

Chemical Structure

L-750,667 TriHydrochloride
L-750,667 TriHydrochloride
CAS#1021868-80-3

Theoretical Analysis

MedKoo Cat#: 532083

Name: L-750,667 TriHydrochloride

CAS#: 1021868-80-3

Chemical Formula: C18H22Cl3IN4

Exact Mass:

Molecular Weight: 527.66

Elemental Analysis: C, 40.97; H, 4.20; Cl, 20.16; I, 24.05; N, 10.62

Price and Availability

Size Price Availability Quantity
5mg USD 585.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
L-750,667; L 750,667; L750,667.
IUPAC/Chemical Name
3-[4-(4-Iodophenyl)piperazin-1-yl]methyl-1H-pyrrolo[2,3-b]pyridine trihydrochloride
InChi Key
YOURSPNOEWYAKO-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H19IN4.3ClH/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18;;;/h1-7,12H,8-11,13H2,(H,20,21);3*1H
SMILES Code
IC1=CC=C(N2CCN(CC3=CNC4=NC=CC=C43)CC2)C=C1.[H]Cl.[H]Cl.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
L-750,667 TriHydrochloride is a selective D4 dopamine receptor antagonist.
In vitro activity:
In contrast to RBI-257 which is an antagonist at all receptors, L-750,667 is a partial agonist at the wild-type D(2) but an antagonist at both the mutant D(2) and wild-type D(4) receptors. Reference: J Neurochem. 2009 Jul;110(1):45-57. https://pubmed.ncbi.nlm.nih.gov/19486266/
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 527.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Cummings DF, Ericksen SS, Schetz JA. Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity. J Neurochem. 2009 Jul;110(1):45-57. doi: 10.1111/j.1471-4159.2009.06103.x. Epub 2009 Apr 16. PMID: 19486266; PMCID: PMC4896224. 2. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S. Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun. 2008 Aug 22;373(2):286-91. doi: 10.1016/j.bbrc.2008.06.012. Epub 2008 Jun 17. PMID: 18558081.
In vitro protocol:
1. Cummings DF, Ericksen SS, Schetz JA. Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity. J Neurochem. 2009 Jul;110(1):45-57. doi: 10.1111/j.1471-4159.2009.06103.x. Epub 2009 Apr 16. PMID: 19486266; PMCID: PMC4896224. 2. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S. Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun. 2008 Aug 22;373(2):286-91. doi: 10.1016/j.bbrc.2008.06.012. Epub 2008 Jun 17. PMID: 18558081.
In vivo protocol:
TBD
1: Kawano M, Takagi R, Kaneko A, Matsushita S. Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses. J Neuroimmunol. 2015 Dec 15;289:43-55. doi: 10.1016/j.jneuroim.2015.10.001. PubMed PMID: 26616870.